Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ozkizilkaya HI"'
Autor:
Ozkizilkaya HI; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Vinocha A; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Dono A; Vivian L. Smith Department of Neurosurgery, The University of Texas, Health Science Center at Houston, Houston, TX 77030, USA., Ogunbona OB; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Toruner GA; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Aung PP; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kamiya Matsuoka C; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Esquenazi Y; Vivian L. Smith Department of Neurosurgery, The University of Texas, Health Science Center at Houston, Houston, TX 77030, USA.; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX 77030, USA.; Memorial Hermann Hospital-TMC, Houston, TX 77030, USA., DeMonte F; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Ballester LY; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Sep 27; Vol. 16 (19). Date of Electronic Publication: 2024 Sep 27.
Autor:
Ozkizilkaya HI; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Johnson JM; Division of Diagnostic Imaging, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA., O'Brien BJ; Division of Cancer Medicine, Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., McCutcheon IE; Division of Surgery, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, USA., Prabhu SS; Division of Surgery, Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, USA., Ghia AJ; Division of Radiation Oncology, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA., Fuller GN; Division of Diagnostic Imaging, Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Division of Pathology and Lab Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Huse JT; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Division of Pathology and Lab Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA., Ballester LY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.; Division of Pathology and Lab Medicine, Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2023 Mar 21; Vol. 5 (1), pp. vdad026. Date of Electronic Publication: 2023 Mar 21 (Print Publication: 2023).
Autor:
Dono A; Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA., El Achi H; Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA., Bundrant BE; Department of Pathology and Laboratory Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA., Goli PS; Rice University, Houston, TX, USA., Zhu P; Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA., Ozkizilkaya HI; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Esquenazi Y; Vivian L. Smith Department of Neurosurgery, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, USA.; Memorial Hermann Hospital-TMC, Houston, TX, USA.; Center for Precision Health, School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, USA., Ballester LY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
Cancer biomarkers : section A of Disease markers [Cancer Biomark] 2023; Vol. 36 (2), pp. 117-131.
Autor:
Mezzacappa, Frank M., Smith, Frankie K., Zhang, Weiwei, Gard, Andrew, Cabuk, Fatmagul Kusku, Gonzalez-Gomez, Ignancio, Monforte, Hector L., Liang, Jiancong, Singh, Omkar, Quezado, Martha M., Aldape, Kenneth D., Gokden, Murat, Bridge, Julia A., Chen, Jie
Publikováno v:
Acta Neuropathologica Communications; 1/30/2024, Vol. 12, p1-13, 13p